2 Growth Stocks With Incredible Potential in the Next 5 Years
Neither is profitable, but both could be on the verge of massive booms in revenue.
Stay updated with breaking news from Zai Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neither is profitable, but both could be on the verge of massive booms in revenue.
Novocure’s electrical field-producing medical device, in combination with standard drug therapies, improved overall survival in a pivotal study that enrolled patients with advanced non-small cell lung cancer. The medtech company now plans to seek regulatory approvals.
Zai Labs is a relative new entrant to the Chinese pharma space and has multiple approvals and a large clinical pipeline. Read more on ZLAB here.
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity ap...